Drug Shortage Report for CATHFLO
Report ID | 227997 |
Drug Identification Number | 02245859 |
Brand name | CATHFLO |
Common or Proper name | ALTEPLASE |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ALTEPLASE |
Strength(s) | 2MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INSTILLATION INSTILLATION |
Packaging size | 2MG VIAL, PACK OF 10 VIALS |
ATC code | B01AD |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-08-02 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-05-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-05-15 | French | Compare |
v3 | 2024-05-15 | English | Compare |
v2 | 2024-05-15 | English | Compare |
v1 | 2024-05-15 | English | Compare |
Showing 1 to 4 of 4